SILICEA

N/A

Manufactured by BM Private Limited

70 FDA adverse event reports analyzed

Last updated: 2026-04-15

About SILICEA

SILICEA is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by BM Private Limited. The most commonly reported adverse reactions for SILICEA include BURNING SENSATION, GASTROINTESTINAL DISORDER, MULTIPLE SCLEROSIS RELAPSE, PAIN IN EXTREMITY, WEIGHT DECREASED. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SILICEA.

Top Adverse Reactions

BURNING SENSATION2 reports
GASTROINTESTINAL DISORDER2 reports
MULTIPLE SCLEROSIS RELAPSE2 reports
PAIN IN EXTREMITY2 reports
WEIGHT DECREASED2 reports
ADVERSE DRUG REACTION1 reports
ALOPECIA1 reports
ANXIETY1 reports
ARTHRITIS1 reports
BLISTER1 reports
BRONCHITIS1 reports
CANDIDIASIS1 reports
CARPAL TUNNEL SYNDROME1 reports
CENTRAL NERVOUS SYSTEM LESION1 reports
CEREBROVASCULAR ACCIDENT1 reports
CONDITION AGGRAVATED1 reports
CUBITAL TUNNEL SYNDROME1 reports
CYST1 reports
DECREASED IMMUNE RESPONSIVENESS1 reports
DENTAL CARIES1 reports
DEPRESSION1 reports
DIARRHOEA1 reports
DRUG INEFFECTIVE1 reports
DRY MOUTH1 reports
DYSPNOEA1 reports
EAR INFECTION1 reports
ECZEMA1 reports
EXOSTOSIS1 reports
GASTROINTESTINAL TOXICITY1 reports
HAEMOGLOBIN DECREASED1 reports
HAND FRACTURE1 reports
HEADACHE1 reports
HYPOAESTHESIA1 reports
IMMUNOGLOBULINS INCREASED1 reports
INFLAMMATION1 reports
JOINT RANGE OF MOTION DECREASED1 reports
JOINT STIFFNESS1 reports
LUMBAR VERTEBRAL FRACTURE1 reports
MOUTH ULCERATION1 reports
MUSCLE ENZYME INCREASED1 reports
MUSCULAR WEAKNESS1 reports
MUSCULOSKELETAL STIFFNESS1 reports
NERVOUSNESS1 reports
OEDEMA PERIPHERAL1 reports
OPTIC NEURITIS1 reports
OSTEOARTHRITIS1 reports
PARAESTHESIA1 reports
PULMONARY EMBOLISM1 reports
PULMONARY HYPERTENSION1 reports
RASH1 reports
RASH ERYTHEMATOUS1 reports
RASH PRURITIC1 reports
RENAL DISORDER1 reports
RHEUMATOID ARTHRITIS1 reports
SICKLE CELL ANAEMIA1 reports
SKIN DISORDER1 reports
SKIN IRRITATION1 reports
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE1 reports
SPINAL FRACTURE1 reports
SPINAL PAIN1 reports
STRESS1 reports
TRIGGER FINGER1 reports
URINARY TRACT INFECTION1 reports
VAGINAL INFECTION1 reports
VITAMIN B12 INCREASED1 reports

Report Outcomes

Out of 8 classified reports for SILICEA:

Serious 75.0%Non-Serious 25.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female7 (87.5%)
Male1 (12.5%)

Reports by Age

Age 501 reports
Age 521 reports
Age 551 reports
Age 711 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with SILICEA?

This profile reflects 70 FDA FAERS reports that mention SILICEA. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for SILICEA?

Frequently reported terms in FAERS include BURNING SENSATION, GASTROINTESTINAL DISORDER, MULTIPLE SCLEROSIS RELAPSE, PAIN IN EXTREMITY, WEIGHT DECREASED, ADVERSE DRUG REACTION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures SILICEA?

Labeling and FAERS entries often list BM Private Limited in connection with SILICEA. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.